Recurrent steroid-responsive pancreatitis associated with myelodysplastic syndrome and transformations

Tawee Tanvetyanon1, Patrick J Stiff

  • 1Division of Hematology and Oncology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, IL 60153, USA. tanvety@pol.net

Leukemia & Lymphoma
|December 29, 2004
PubMed

Insights

Recurrent acute pancreatitis, previously undescribed in myelodysplastic syndromes (MDS), was observed in a patient. This autoimmune pancreatitis responded to immunosuppression, suggesting a paraneoplastic link to MDS and acute myeloid leukemia (AML).

Area of Science:

  • Hematology
  • Gastroenterology
  • Immunology

Background:

  • Myelodysplastic syndromes (MDS) are associated with various paraneoplastic inflammatory conditions, primarily autoimmune diseases.
  • Recurrent acute pancreatitis has not been previously documented as a paraneoplastic manifestation of MDS.

Observation:

  • A 44-year-old male with MDS (refractory anemia with excess blast type 2) presented with fever, fatigue, aortitis, and pericarditis.
  • Acute pancreatitis developed upon corticosteroid tapering for vasculitis and recurred with drug discontinuation.
  • Pancreatitis episodes resolved with increased corticosteroid dosage and chemotherapy for transformation to acute myeloid leukemia (AML).

Findings:

  • The patient experienced recurrent acute pancreatitis, strongly linked temporally and in severity to MDS and subsequent AML.
  • All other causes of pancreatitis were excluded.
  • The pancreatitis demonstrated a dramatic response to immunosuppressive therapy, indicating an autoimmune etiology.

Implications:

  • This case suggests autoimmune pancreatitis can be a paraneoplastic phenomenon associated with myelodysplastic syndromes and acute myeloid leukemia.
  • The findings expand the spectrum of paraneoplastic inflammatory conditions linked to MDS.
  • Further research is warranted to explore the mechanisms and prevalence of MDS-associated autoimmune pancreatitis.

Related Concept Videos

Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...